相似文献
1
Reply to 'development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani F et al.
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e976-e978. doi: 10.1111/jdv.18398. Epub 2022 Jul 12.
2
Reply to 'Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani et al.
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e750-e751. doi: 10.1111/jdv.18302. Epub 2022 Jun 17.
3
Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e649-e651. doi: 10.1111/jdv.17480. Epub 2021 Jul 12.
4
Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation.
Dermatol Ther. 2022 May;35(5):e15396. doi: 10.1111/dth.15396. Epub 2022 Mar 15.
5
Immediate reactions after mRNA SARS-CoV-2 vaccination.
CMAJ. 2021 Dec 6;193(48):E1842. doi: 10.1503/cmaj.211581. Epub 2021 Nov 12.
6
De novo severe pemphigus vulgaris following SARS-CoV-2 vaccination with BBIBP-CorV.
Dermatol Ther. 2022 Jun;35(6):e15448. doi: 10.1111/dth.15448. Epub 2022 Mar 20.
7
Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac).
J Infect. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2022.12.016. Epub 2022 Dec 17.
8
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases.
J Rheumatol. 2022 Mar;49(3):334-335. doi: 10.3899/jrheum.210863. Epub 2022 Jan 15.
9
Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study' by Shasha et al.
Clin Microbiol Infect. 2022 Mar;28(3):452-453. doi: 10.1016/j.cmi.2021.11.013. Epub 2021 Nov 25.
10
Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination.
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e415-e416. doi: 10.1111/jdv.17225. Epub 2021 Apr 19.
引用本文的文献
1
Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review.
Viruses. 2024 Dec 9;16(12):1896. doi: 10.3390/v16121896.
2
New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review.
Vaccines (Basel). 2024 Apr 26;12(5):465. doi: 10.3390/vaccines12050465.
3
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?
Life (Basel). 2023 Apr 18;13(4):1037. doi: 10.3390/life13041037.
4
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review.
Clin Cosmet Investig Dermatol. 2022 Dec 19;15:2785-2793. doi: 10.2147/CCID.S377029. eCollection 2022.
Zotero 插件